N@N

Trump to meet pharma leaders as they seek drug policy changes

The article from MSN discusses former President Donald Trump's planned meeting with pharmaceutical industry leaders to discuss potential changes in drug policy. This meeting comes at a time when the pharmaceutical sector is seeking to influence policy, particularly in light of recent legislative changes and ongoing debates about drug pricing, innovation, and regulation. The industry leaders are likely to push for policies that could benefit their business interests, such as reducing regulatory hurdles, protecting intellectual property rights, and addressing issues related to drug pricing and market access. Trump, known for his past interactions with the pharmaceutical industry, might leverage this meeting to outline his stance on these issues, possibly hinting at his policy direction should he return to office. The discussions could also touch on the implications of the Inflation Reduction Act, which allows Medicare to negotiate drug prices, a move that has been contentious among pharmaceutical companies.

Read the Full MSN Article at:
[ https://www.msn.com/en-my/news/politics/trump-to-meet-pharma-leaders-as-they-seek-drug-policy-changes/ar-AA1zpfbg ]